Syremis

1 stories about Syremis
מוח Brain Medtech

Syremis raises $165 million Series A to take on schizophrenia and other severe mental illnesses

21.12.25|CTech
Teva veterans launch a new drugmaker targeting long-neglected psychiatric conditions.